PlanetRx.com
This article was originally published in The Tan Sheet
Executive Summary
E-tailer verging on NASDAQ delisting as stock fails to remain above the $1 minimum bid price. Company's troubles follow a last-ditch, 8-for-1 reverse stock split cleared by the exchange Dec. 1. Since October, the company has not managed to raise stock prices above 50[cents], closing at 31[cents] Jan. 5. PlanetRx's delisting has been stayed pending a qualifications panel hearing, the company said